Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

AbbVie (NY: ABBV )

202.08 +1.20 (+0.60%)
Official Closing Price Updated: 7:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,889,380
Open 200.32
Bid (Size) 201.11 (3)
Ask (Size) 201.95 (1)
Prev. Close 200.88
Today's Range 200.01 - 203.97
52wk Range 153.58 - 207.32
Shares Outstanding N/A
Dividend Yield 3.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Large Cap Biopharmaceutical Metrics And Performance Q1 2025
Tariffs could have big impact on earnings in 2025. 
Via Talk Markets
Topics Stocks / Equities
2 Magnificent Dividend Growth Stocks to Load Up On Right Now
Via The Motley Fool

Performance

YTD
+12.62%
+12.62%
1 Month
+19.43%
+19.43%
3 Month
+14.20%
+14.20%
6 Month
+2.29%
+2.29%
1 Year
+14.33%
+14.33%

More News

Read More
4 Stocks and 1 Exchange-Traded Fund (ETF) I Can't Stop Buying
Via The Motley Fool
What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings
Via StockStory
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
Via Benzinga
Topics Government
Exposures Political
How Is The Market Feeling About AbbVie?
Via Benzinga
Is AbbVie Stock a Buy Now?
Via The Motley Fool
Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
Via Benzinga
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
From Xilio Therapeutics, Inc.; AbbVie Inc.
Via GlobeNewswire
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
Via StockStory
Healthcare And Biotech Playbook As Disruption Gathers Force
Via Talk Markets
Topics ETFs Stocks / Equities
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
These Stocks Missed on Earnings, But Will Rebound Next Quarter
Via MarketBeat
Gilead Sciences (GILD) Q4 Earnings: What To Expect
Via StockStory
3 Fabulous Dividend Stocks to Buy in February
Via The Motley Fool
Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For
Via StockStory
Earnings To Watch: Incyte (INCY) Reports Q4 Results Tomorrow
Via StockStory
3 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
These 2 Dividend Stocks Are Absolute Bargains Right Now
Via The Motley Fool
3 Top AI-Powered Biotech Stocks to Buy in February
Via The Motley Fool
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Can Biotech Stocks Survive The Precarious Macro?
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Top S&P500 movers in Monday's session
Via Chartmill
Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.